corporary

HRA PHARMA DEVELOPMENT

Ceased
SIREN 433432176 VAT number FR94433432176

Business purpose.

La commercialisation et l'exploitation de tous produits pharmaceutique, para pharmaceutique, médicaux, para médicaux, vétérinaires, para vétérinaires, chimiques et plus généralement de tous produits concernant ou pouvant concerner la société. La prestation de services en matière de pharmacovigilance.

HRA PHARMA DEVELOPMENT is a company registered under SIREN number 433432176, with its registered office in CHATILLON. Its main activity falls under the sector: Wholesale trade, except of motor vehicles and motorcycles. It is administratively ceased. It has 3 establishments. 1 serving director is recorded in the national business register. Its reported revenue for the financial year ended in 2018 is 0 euros.

Sources: INSEE Sirene, INPI RNE, INPI, annual accounts.

Identity

Legal form
SARL (no further detail)
Activity
Wholesale (intercompany trade) of pharmaceutical goods (46.46Z)
Sector
Wholesale trade, except of motor vehicles and motorcycles
Headcount
Headcount unknown
Created
19 Sep 2000
Share capital
8,000.00 EUR
Registered with the trade register
30 Oct 2000
Financial year end
31/12
Establishments
3

Directors

Related companies

Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.

Other companies at the same address

23 other company head offices are registered at this address.

Establishments

Financial strength

Financial score

Cannot be computed, not enough data

Confidence: low · computed on the financial year ended 31 Dec 2018

Equity to assets (100.0 %)
30.0 out of 30
EBITDA margin
data missing, component not taken into account
Liquidity
data missing, component not taken into account
Debt (0.0 %)
15.0 out of 15
Revenue trend
data missing, component not taken into account

formula fin-1.0

Legal score

60 / 100 C

Confidence: high

No insolvency proceedings
40.0 out of 40
Currently trading
0.0 out of 20
Age (26.2 years)
20.0 out of 20
Accounts filed recently
0.0 out of 20

formula leg-1.0

These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated

Revenue and earnings

Detailed accounts for this company are not reproduced here, but its main aggregates are public.

Revenue and net income by financial year
2015 2016 2017 2018

Revenue Net income

Financial year Revenue Change EBITDA Net income
31 Dec 2018 0 € — -22,588 € 175,412 €
31 Dec 2017 0 € — -1,473 € -1,473 €
31 Dec 2016 0 € — -426 € -426 €
31 Dec 2015 0 € first year on record -490 € -549 €

Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.

Explore similar companies

Legal notices

  • Striking off 4 Jan 2022
    Court :
    Greffe du Tribunal de Commerce de Nanterre

    BODACC B n 20220002, annonce n 3132 · Proof of publication (PDF)

  • Amendment 9 Dec 2021
    Court :
    Greffe du Tribunal de Commerce de Nanterre
    Amendment :
    transmission universelle du patrimoine.

    BODACC B n 20210239, annonce n 4193 · Proof of publication (PDF)

  • Filing of accounts 4 Jun 2019
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE NANTERRE
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2018

    BODACC C n 20190106, annonce n 10850 · Proof of publication (PDF)

Annual accounts as PDF →

Change history

  • officer_appointed (empty) → Gerant 9 Oct 2026
  • registered_address (empty) → 200 Avenue de Paris 92320 Châtillon 1 Oct 2026
  • capital (empty) → 8000.00 1 Oct 2026

Frequently asked questions about HRA PHARMA DEVELOPMENT

What is the SIREN number of HRA PHARMA DEVELOPMENT?
The SIREN number of HRA PHARMA DEVELOPMENT is 433432176. Its intra-community VAT number is FR94433432176.
Where is the head office of HRA PHARMA DEVELOPMENT?
Head office address: 200 AV DE PARIS, 92320 CHATILLON.
When was HRA PHARMA DEVELOPMENT founded?
HRA PHARMA DEVELOPMENT was founded on 19 Sep 2000. It ceased trading on 31 Dec 2021.
What does HRA PHARMA DEVELOPMENT do?
Its declared main activity is: Wholesale (intercompany trade) of pharmaceutical goods (NAF code 46.46Z).
Who runs HRA PHARMA DEVELOPMENT?
The officer listed in the register is DAVID WRIGHT (Gerant).
What is the revenue of HRA PHARMA DEVELOPMENT?
The latest published revenue is 0 €, for the 2018 financial year.
Is HRA PHARMA DEVELOPMENT subject to insolvency proceedings?
No ongoing insolvency proceedings are published in the BODACC for this company.

In the official registers

Further reading

Report an error or request removal of this data